FJX1 drives FOLFOX resistance via PPARγ-mediated EMT and serves as a prognostic biomarker in colorectal cancer.
- DOI
- 10.1016/j.tranon.2026.103046
- Published
- 2026 Sep 23
- Container
- Translational oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.tranon.2026.103046,
title = {FJX1 drives FOLFOX resistance via PPARγ-mediated EMT and serves as a prognostic biomarker in colorectal cancer.},
author = {Yang M and Tian Z and Guo Y and Wang Y and Dai W and Si T},
year = {2026},
journal = {Translational oncology},
doi = {10.1016/j.tranon.2026.103046},
url = {https://doi.org/10.1016/j.tranon.2026.103046}
}RIS
TY - JOUR TI - FJX1 drives FOLFOX resistance via PPARγ-mediated EMT and serves as a prognostic biomarker in colorectal cancer. AU - Yang M AU - Tian Z AU - Guo Y AU - Wang Y AU - Dai W AU - Si T PY - 2026 JO - Translational oncology DO - 10.1016/j.tranon.2026.103046 UR - https://doi.org/10.1016/j.tranon.2026.103046 ER -
APA
M, Y., Z, T., Y, G., Y, W., W, D., & T, S. (2026). FJX1 drives FOLFOX resistance via PPARγ-mediated EMT and serves as a prognostic biomarker in colorectal cancer.. Translational oncology. https://doi.org/10.1016/j.tranon.2026.103046
Source records
- pubmed · retrieved 2026-09-25T18:32:01.208Z